10 hours ago
Petra Capital Sticks to Their Buy Rating for Artrya Limited (AYA)
In a report released yesterday, Tanushree Jain from Petra Capital maintained a Buy rating on Artrya Limited (AYA – Research Report), with a price target of A$2.81. The company's shares opened today at A$0.67.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jain covers the Healthcare sector, focusing on stocks such as Neuren Pharmaceuticals Limited, Dimerix Limited, and Artrya Limited. According to TipRanks, Jain has an average return of 23.6% and a 44.12% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Artrya Limited with a A$2.81 average price target.
The company has a one-year high of A$1.04 and a one-year low of A$0.20. Currently, Artrya Limited has an average volume of 250.8K.
